VEGFA and cancer: Tyrosine kinase inhibitors (TKI) play an increasingly important role in the therapy of multiple malignancies and the development of compounds targeting, for example, the vascular endothelial growth factor (VEGF)/VEGF receptor (VEGFR) signaling pathway has led to key advances in the treatment of different cancer types [1,2,3].